Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

About this update from Bio-rad Laboratories, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/52d1faf292d55bba9744ef3dca528442"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1Nz6CQkOgbYaX.WHsXRTGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/52d1faf292d55bba9744ef3dca528442","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/J.qtGq0ksba7k_qqODAXvg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/52d1faf292d55bba9744ef3dca528442","width":1024,"height":512}},"lazy":false},{"type":"text","content":"HERCULES, Calif., February 12, 2026--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full-year ended December 31, 2025.","length":275,"tagName":"p"},{"type":"text","content":"Norman Schwartz, Bio-Rad’s Chief Executive Officer, stated: "2025 was a challenging year with geopolitical uncertainty and continued pressure on academic research funding affecting our end markets. While we delivered modest revenue growth and strong free cash flow, our gross and operating margin performance fell below our expectations. The recent acquisition of digital PCR developer Stilla Technologies has been successfully integrated, and we are pleased with the initial market adoption of our expanded ddPCR™ product portfolio. As we enter 2026, we remain committed to improving overall performance."","length":616,"tagName":"p"},{"type":"text","content":"Financial Results Highlights","length":28,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"13","rowspan":"1","style":"vertical-align:bottom;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;background-color:#CCEEFF;padding-left:0.0px;","val":[{"type":"text","content":"GAAP Results","length":12,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:bottom;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;padding-left:0.0px;width:32%;","val":[{"type":"text","content":"&n...

View stock analysis, news, and events for Bio-rad Laboratories, Inc.